Evaluation of thyrotoxicosis during pregnancy with color flow Doppler sonography

[1]  P. Vitti,et al.  Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[2]  A. Miyauchi,et al.  Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves’ disease , 2007, Clinical endocrinology.

[3]  M. Erdoğan,et al.  Color flow Doppler sonography for the etiologic diagnosis of hyperthyroidism. , 2007, Thyroid : official journal of the American Thyroid Association.

[4]  S. Kaneko,et al.  Measurement of thyroid blood flow area is useful for diagnosing the cause of thyrotoxicosis. , 2005, Thyroid : official journal of the American Thyroid Association.

[5]  T. Takano,et al.  Simple and practical parameters for differentiation between destruction‐induced thyrotoxicosis and Graves’ thyrotoxicosis , 2002, Clinical endocrinology.

[6]  G. Fürst,et al.  Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[7]  H. Arslan,et al.  Power Doppler sonography in the diagnosis of Graves' disease. , 2000, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[8]  L Manetti,et al.  Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. , 1999, European journal of endocrinology.

[9]  M. Salvatori,et al.  Diagnostic imaging in thyrotoxicosis. , 1999, Rays.

[10]  K. Kasagi,et al.  Comparison of serum thyrotrophin concentrations determined by a third generation assay in patients with various types of overt and subclinical thyrotoxicosis , 1999, Clinical endocrinology.

[11]  K. Usadel,et al.  Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.

[12]  J. Womersley,et al.  Measurement of the W boson mass at the LHC , 1997, hep-ph/9711304.

[13]  K. Kuma,et al.  Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. , 1996, The Journal of clinical endocrinology and metabolism.

[14]  Elena S. Di Martino,et al.  Thyroid blood flow evaluation by color-flow doppler sonography distinguishes Graves’ disease from Hashimoto’s thyroiditis , 1995, Journal of endocrinological investigation.

[15]  Color-Flow Doppler Sonography in Graves Disease: "Thyroid Inferno" , 1988 .

[16]  K. P. Lee,et al.  Color-flow Doppler sonography in Graves disease: "thyroid inferno". , 1988, AJR. American journal of roentgenology.

[17]  N. Amino,et al.  DIFFERENTIATION OF THYROTOXICOSIS INDUCED BY THYROID DESTRUCTION FROM GRAVES' DISEASE , 1978, The Lancet.

[18]  S. Werner.  Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. , 1977, The Journal of clinical endocrinology and metabolism.

[19]  T. Prout.  Thyroid disease in pregnancy. , 1966, American journal of obstetrics and gynecology.

[20]  W. London,et al.  Letter: Cross-reaction of antibodies to human lactoferrin with HBAg. , 1974, Lancet.